Semaglutide Plus Program

What is Semaglutide Plus?

Semaglutide is a glucagon-like peptide 1 (GLP-1) hormone produced in the gut and released in response to food. It causes reduced appetite and the release of insulin. Semaglutide injection also known as Wegovy or Ozempic is used in combination with a reduced-calorie/carbohydrate, low-fat diet and exercise program to help with weight loss in overweight and obese adults. Semaglutide injection works by helping the pancreas to release the right amount of insulin when blood sugar levels are high. Insulin helps move sugar from the blood into other body tissues where it is used for energy. Semaglutide injection also works by slowing the movement of food through the stomach and may decrease appetite and cause weight loss.

Levocarnitine is an amino acid that benefits energy levels by transporting fatty acids into the mitochondria, where they can be used as energy. L-carnitine plays an essential role in the transportation of fats to the mitochondria, where they’re converted to energy. For this reason, many take carnitine as a weight-loss supplement to help accelerate fat burning.

Benefits of Semaglutide Plus?

  • Reduces food intake by lowering appetite

  • Slows food digestion in the stomach

  • Decreases body fat percentage

  • Weight loss

  • Decreased cardiovascular outcomes in individuals with type 2 diabetes and cardiovascular disease

  • Lowers HbA1c levels

  • Enhance the growth of β cells in the pancreas

States semaglutide plus can be shipped to...

AK, AZ, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, MA, MD, ME, MO, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, UT, VA, VT, WI, WY, PUERTO RICO

Who can take Semaglutide Plus?

Semaglutide Plus compound injection is used to treat overweight individuals with an initial body mass index (BMI) of ≥ 27 kg/m2 with at least one weight-related comorbidity or obese individuals with a (BMI) ≥ 30 kg/m2. 

Who should not take Semaglutide Plus?

Semaglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with multiple endocrine neoplasia syndrome type 2 (MENS2).

Although low, there is a potential risk for MTC with semaglutide and possible symptoms of thyroid tumors (eg, a mass in the neck, difficulty swallowing, shortness of breath, persistent hoarseness). You should not take semaglutide if you have a known hypersensitivity to semaglutide or any of the product components.

Syringe

Semaglutide Plus compound

​Our semaglutide plus is shipped directly from the compounding pharmacy to your address.

The dosing schedule is:

  • Week 1 - 4 = 0.25 mg (9.5 units) SQ weekly

  • Week 5 - 8 = 0.50 mg (19 units) SQ weekly

  • Week 9 - 12 = 1.0 mg (38 units) SQ weekly

  • Week 13 - 16 = 1.7 mg (66 units) SQ weekly

  • Week 17 and greater = 2.4 mg (92 units) weekly

We recommend starting on the lowest dose and staying on that dose if you are achieving appetite suppression. Semaglutide plus is a once weekly injection administered with insulin needles.

Common side effects:

Nausea, diarrhea, vomiting, constipation, stomach pain, headache, fatigue, upset stomach, dizziness, feeling bloated, belching, and gas.

Drug and Syringe
Online Meeting

How do I get started?

For new clients, you must book an initial prescription pro​gram visit. Returning clients who have already had an initial prescription visit can book a follow-up prescription visit.

Cost:

  • Initial prescription program visit: $175

  • Required to purchase a 4 prepaid follow-up package: $240

  • Cost of 1 (2ml) semaglutide plus vial with needles: $300

  • Total cost: $715 includes your initial visit, 4 months of follow-up visits and one vial of semaglutide plus. One vial will last 2-20 weeks depending on the dose.